CD86 and COVID-19: Moreover, COVID-19 monocytes exhibited a similar profile as monocytes from patients with hepatitis C, in which upregulation of PD-L1 and IL-10, and downregulation of HLA-DR and CD86 were the hallmark of the infection [42].